For Immediate Release
Chicago, IL – April 18, 2017 – Today, Zacks Investment Ideas feature highlights Features: IBM (NYSE: IBM – Free Report ), Lam Research (NASDAQ:LRCX – Free Report ), eBay (NASDAQ: EBAY – Free Report ) and NCR Corp (NYSE: NCR – Free Report ).
This Week in Tech Stocks
The calendar is heating up this week for tech stocks. We have several companies reporting earnings. One newer name that is coming out of its quiet period. Finally, there is one stock that is seeing its lockup expire so we will touch on that too.
Earnings This Week
Tuesday after the close we have two big tech names in IBM (NYSE:IBM – Free Report ) and Lam Research (NASDAQ:LRCX – Free Report ). IBM has topped the Zacks Consensus Estimate in each of the last 6 quarters but the price reaction following the report has not been all that positive. Add to that the idea revenue will show a year over year decrease and a 0% Earnings ESP score and sitting this one out might be the best most. LRCX is a Zacks Rank #2 (Buy) that has also beaten the Zacks Consensus Estimate in each of the last 6 quarters and has seen its stock move less than 4% (up or down) following all of those reports. A good strategy for that play could be an options strangle.
Follow Brian Bolan on Twitter: BBolan1
Wednesday has eBay (NASDAQ: EBAY – Free Report ), a Zacks Rank #3 (Hold). Both have Earnings ESP of 0% so there isn’t too much to go on there. I see that EBAY missed the most recent quarter yet the stock advanced by 5.8% in the session following the announcement. EBAY tends to move following earnings so an options straddle might make some sense as the stock moved +12.9% two times and -13.2% once in the last six quarters. The smallest move was a 4.3% advance following the March 2016 quarter.
Thursday after the close will see numbers from NCR Corp (NYSE:NCR – Free Report ). I have written about NCR being a beneficiary of new technology for ATM machines, but investors should really be cashing in on this stock. Right now, NCR is a Zacks Rank #2 (Buy) that has an “A” for the Growth and Value style score. Trading at 13x forward earnings is great, but add to that a solid history of beating the number and you have something worth taking a deeper look at.
Quiet Period Ending
After a company holds an IPO the investment banks that took the stock public tend to wait 25 days before initiating coverage. Look for new coverage to come from Goldman, JP Morgan, Barclays, Citi, Pacific Crest, William Blair, JMP Securities, Raymond James and Cowen for Alteryx. The company priced 9M shares at $14 and they opened for trading at $17.25. That turned out to be very close to the high, which was reached later that day at $17.50.
AYX doesn’t have a Zacks Rank yet as the rank is based on earnings estimate revisions from the brokerages that cover the stock. Keep in mind that this is a pretty small company (roughly $150M in market cap) but it looks to have some big name coverage soon. That should get the story to some of the bigger institutions, but most of the bigger institutions have a requirement that investments only be made in stocks that are over $1B in market cap.
As part of the IPO process, the underwriters usually include a lockup clause to restrict insiders from selling their shares. Usually, this is 180 days following the IPO. The end of the lockup has come for Crispr Therapeutics and there are now 27,135,884 shares that can be sold. Thing is, I would not expect much more than 1% of that total to find its way to the market. The stock only trades about 65K shares per day, so even if an insider wanted to dispose of 7K shares that would be 10% of a day’s trading and would likely impact the price.
Right now I see CRSP up 2% on volume of around 22K shares. So if you wanted to short this one into the lock up, you probably made the wrong move. CRSP has yet to get a Zacks Rank.
Follow Brian Bolan on Twitter: @BBolan1
Want more articles from this author? Go to Zacks.com on this article and click the FOLLOW AUTHOR button to get an email each time a new article is published.
Brian Bolan is a Stock Strategist for Zacks.com.
He runs Stocks Under $10 Investor service where he looks for low priced stocks that are seeing positive earnings estimate revisions. This popular service has seen some strong early returns and offers a free trial via the Zacks Ultimate service.
Brian also runs the brand new Zacks Game Changers where he looks for stocks that are disrupting their industries and reaping big gains.
Looking for Ideas with Even Greater Upside?
Today's investment ideas are short-term, directly based on our proven 1 to 3 month indicator. In addition, I invite you to consider our long-term opportunities. These rare trades look to start fast with strong Zacks Ranks, but carry through with double and triple-digit profit potential. Starting now, you can look inside our home run, value, and stocks under $10 portfolios, plus more. Click here for a peek at this private information>>
Get the full Report on EBAY – FREE
Get the full Report on IBM – FREE
Get the full Report on NCR – FREE
Get the full Report on LRCX – FREE
Follow us on Twitter: https://twitter.com/ZacksResearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
International Business Machines Corporation (IBM): Free Stock Analysis Report
Lam Research Corporation (LRCX): Free Stock Analysis Report
eBay Inc. (EBAY): Free Stock Analysis Report
NCR Corporation (NCR): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research